This company has been marked as potentially delisted and may not be actively trading. Catalyst Pharmaceuticals (CPRX) News Today Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsEarningsInsider TradesNews and TrendsOwnershipShort Interest Catalyst Pharmaceuticals Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Italy's Angelini Pharma completes $4.1 billion state-backed takeover of CatalystJuly 16, 2026 | reuters.comAngelini Pharma Completes Acquisition of Catalyst PharmaceuticalsJuly 16, 2026 | globenewswire.comSolaris Energy Infrastructure to join S&P SmallCap 600, replacing Catalyst PharmaJuly 10, 2026 | msn.comSanthera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®July 1, 2026 | finance.yahoo.comVamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical DosesJune 30, 2026 | globenewswire.comCatalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRXJune 24, 2026 | businesswire.comAngelini Buyout And FIRDAPSE Settlement Reframe Catalyst Pharmaceuticals StoryMay 20, 2026 | finance.yahoo.comCatalyst Pharmaceuticals: Angelini Deal Caps A Potentially Better StoryMay 13, 2026 | seekingalpha.comAre CPRX, UNF, RMAX, ACR Obtaining Fair Deals for their Shareholders?May 12, 2026 | prnewswire.comCatalyst Pharmaceuticals Reports First Quarter 2026 Financial ResultsMay 11, 2026 | globenewswire.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)May 11, 2026 | globenewswire.comCatalyst Pharmaceuticals Buyout And FIRDAPSE Patents Reframe Investor OutlookMay 10, 2026 | finance.yahoo.comCatalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRXMay 9, 2026 | businesswire.comCitigroup downgrades Catalyst Pharmaceuticals (CPRX)May 9, 2026 | msn.comStephens & Co. downgrades Catalyst Pharmaceuticals (CPRX)May 8, 2026 | msn.comCatalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and WebcastMay 8, 2026 | markets.businessinsider.comAngelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare ...May 7, 2026 | markets.businessinsider.comAngelini Pharma to buy Catalyst Pharmaceuticals for $4.1BMay 7, 2026 | seekingalpha.comShareholder Alert: Ademi LLP investigates whether Catalyst Pharmaceuticals Inc. is obtaining a Fair Price for Public ShareholdersMay 7, 2026 | prnewswire.comCPRX Stock Alert: Halper Sadeh LLC is Investigating Whether Catalyst Pharmaceuticals, Inc. is Obtaining a Fair Price for its ShareholdersMay 7, 2026 | businesswire.comCatalyst Pharma to Be Acquired by Angelini Pharma in $4.1 Billion DealMay 7, 2026 | wsj.comCatalyst Pharmaceuticals and Hetero Labs Ltd. Settle FIRDAPSE Patent Litigation; Hetero to Market Generic Version Starting January 2035May 7, 2026 | quiverquant.comQCatalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.May 7, 2026 | globenewswire.comItaly's Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1 billionMay 7, 2026 | reuters.comAngelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare DiseaseMay 7, 2026 | globenewswire.comAngelini Interest Puts Catalyst Pharmaceuticals Rare Disease Value In FocusMay 6, 2026 | finance.yahoo.comA Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price MomentumApril 30, 2026 | finance.yahoo.comCatalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026April 28, 2026 | globenewswire.comCatalyst Pharmaceuticals stock surges on takeover reportApril 27, 2026 | investing.comCatalyst Pharmaceuticals jumps on report of interest from Angelini PharmaApril 27, 2026 | msn.comCatalyst Pharmaceuticals: Favorable Trial Outcome Could Be A Meaningful OverhangApril 26, 2026 | seekingalpha.comStocks to watch: Catalyst Pharmaceuticals sees relative strength rating rise to 84April 25, 2026 | msn.comHow Rare-Disease Drug Momentum At Catalyst Pharmaceuticals (CPRX) Has Changed Its Investment StoryApril 25, 2026 | finance.yahoo.comInstitutional Support And Deal Pipeline Shape Outlook For Catalyst PharmaceuticalsApril 17, 2026 | finance.yahoo.comAssessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price StrengthApril 14, 2026 | finance.yahoo.comIf You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have NowApril 10, 2026 | msn.comCatalyst Pharmaceuticals Inc. stock rises Wednesday, still underperforms marketApril 8, 2026 | marketwatch.comCatalyst Pharmaceuticals (CPRX) Is Up 5.0% After Extending Firdapse Exclusivity And Launching Agamree - Has The Bull Case Changed?April 7, 2026 | finance.yahoo.comCatalyst Pharmaceuticals joins elite list of stocks with 95-plus composite ratingApril 1, 2026 | msn.comIs Catalyst Pharmaceuticals (CPRX) Still Attractively Priced After Recent Share Price Stability?March 31, 2026 | finance.yahoo.comAssessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Trading And DCF Upside SignalsMarch 30, 2026 | finance.yahoo.comCatalyst Pharmaceuticals Inc.March 24, 2026 | barrons.comA Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price SoftnessMarch 16, 2026 | finance.yahoo.comIs Catalyst Pharmaceuticals (CPRX) Pricing Reflect Long Term Value After Rare Disease Interest?March 16, 2026 | finance.yahoo.comCatalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptMarch 10, 2026 | seekingalpha.comCatalyst Pharmaceuticals: Exceptional Fundamentals Trading at 20-33% DiscountMarch 10, 2026 | uk.finance.yahoo.comCatalyst Pharmaceuticals to Present Real-World Findings on Duchenne Muscular Dystrophy at 2026 MDA ConferenceMarch 6, 2026 | quiverquant.comQCatalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific ConferenceMarch 6, 2026 | globenewswire.comCatalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading dayMarch 2, 2026 | marketwatch.comIs Catalyst Pharmaceuticals (CPRX) Pricing Reflect Its Strong DCF Upside After Recent Flat ReturnsMarch 1, 2026 | finance.yahoo.com Catalyst Pharmaceuticals Media Mentions By Week Catalyst Pharmaceuticals Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPRX News Sentiment▼0.000.69▲Average Healthcare News Sentiment Catalyst Pharmaceuticals News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPRX Articles This Week▼04▲CPRX Articles Average Week Catalyst Pharmaceuticals Trends on MarketBeatThis week vs. last weekNew Followers2+100%Searches1Page Views1,570-11% Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NBIX News JAZZ News CORT News ELAN News RDY News AXSM News LNTH News AMRX News BLTE News RGC News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Catalyst Pharmaceuticals dated 7/16/2026. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
